---
layout: default
title: Calcium Gluconate
parent: 僅模型預測 (L5)
nav_order: 54
evidence_level: L5
indication_count: 0
---

# Calcium Gluconate
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Calcium Gluconate: No Repurposing Predictions Available

## One-Sentence Summary

Calcium gluconate is a well-established calcium salt compound used clinically for electrolyte management and conditions such as hypocalcemia.
The TxGNN model **did not generate any new indication predictions** for this compound in the current analysis run.
Without predicted indications, a formal repurposing pathway evaluation cannot be completed at this stage; a **Hold** decision is recommended pending data remediation.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | No formal indication data recorded in this Evidence Pack |
| Predicted New Indication | None generated |
| TxGNN Prediction Score | N/A |
| Evidence Level | N/A |
| Philippines Market Status | ✗ Not Marketed |
| Number of Registrations | 0 |
| Recommended Decision | Hold |

---

## Philippines Market Information

There are currently **no Philippine FDA registrations** on record for Calcium gluconate (DrugBank: DB11126) in this Evidence Pack. The drug is classified as **not marketed** in the Philippines.

> No license entries are available to tabulate.

---

## Safety Considerations

Please refer to the package insert for safety information.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN model returned an empty prediction list for Calcium gluconate, and all critical evaluation inputs — original indication, mechanism of action, safety warnings, and contraindication data — are absent or unconfirmed. There is no evidence base upon which to build a repurposing case at this time.

**To proceed, the following is needed:**

- **Investigate the empty prediction output** — confirm that the DrugBank ID `DB11126` is correctly mapped in the knowledge graph (`node.csv` / `kg.csv`) and that the drug node has sufficient edges to generate predictions; if the node is isolated or absent, re-run the KG pipeline after patching the mapping.
- **Obtain mechanism of action (MOA) data** — query the DrugBank API for DB11126 to populate the pharmacological class and target information needed for mechanistic rationale analysis.
- **Obtain safety profile** — download the Philippine FDA (or reference-country) package insert PDF and parse warnings, contraindications, and drug interaction sections to clear data gaps DG001 and DG002.
- **Confirm original indication(s)** — the `original_indications` array is empty; populate from the DrugBank "Indication" field or authoritative label to enable the standard indication-to-new-indication comparison.
- **Re-run TxGNN prediction pipeline** — once data gaps are remediated, re-execute the KG and deep-learning prediction steps and regenerate the Evidence Pack (target version: v5).
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

